Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer

The objective of this study was to determine the proportion of phase 3 clinical trials investigating a systemic therapy for patients with prostate, breast, lung, or colorectal cancer that excluded patients with Chronic Kidney Disease (CKD) and the exclusion criteria chosen, if any. A search was cond...

Descripción completa

Detalles Bibliográficos
Autores principales: Delaye, Matthieu, Rousseau, Adrien, Try, Mélanie, Massard, Christophe, Campedel, Luca, Hilmi, Marc, Bagnis, Corinne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
BRIEF COMMUNICATION
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939176/
https://www.ncbi.nlm.nih.gov/pubmed/36156460
http://dx.doi.org/10.1002/cam4.5171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939176/
https://www.ncbi.nlm.nih.gov/pubmed/36156460
http://dx.doi.org/10.1002/cam4.5171

Ejemplares similares